Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Friede

Showing results (321-330 of 393) with videos related to

Pageof 40
Sort By:
Clinical Genetics|October 11, 2020
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trialJan Boeckhaus, Julia Hoefele, Korbinian M Riedhammer, et al.
Journal of Clinical Medicine|July 24, 2021
Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort StudyOliver Gross, Onnen Moerer, Thomas Rauen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trialsEmmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
European Heart Journal|December 19, 2025
Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trialJaved Butler, Muhammad Shahzeb Khan, Tim Friede, et al.
Journal of Molecular and Cellular Cardiology|September 9, 2022
Direct proteomic and high-resolution microscopy biopsy analysis identifies distinct ventricular fates in severe aortic stenosisSören Brandenburg, Lena Drews, Hanne-Lea Schönberger, et al.
Orphanet Journal of Rare Diseases|October 26, 2018
Recent advances in methodology for clinical trials in small populations: the InSPiRe projectTim Friede, Martin Posch, Sarah Zohar, et al.
Kidney International|April 18, 2020
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndromeOliver Gross, Burkhard Tönshoff, Lutz T Weber, et al.
BMC Cancer|February 6, 2025
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trialMichael Ghadimi, Uwe Pelzer, Marc G Besselink, et al.
Data in Brief|December 12, 2018
Data on differential multivariable risk prediction of appropriate shock vs. competing mortalityLeonard Bergau, Rik Willems, David J Sprenkeler, et al.
American Heart Journal|April 30, 2017
Toward evidence-based diagnosis of myocarditis in children and adolescents: Rationale, design, and first baseline data of MYKKE, a multicenter registry and study platformDaniel R Messroghli, Thomas Pickardt, Marcus Fischer, et al.
Pageof 40

Showing results (321-330 of 393) with videos related to

Sort By:
Pageof 40
Clinical Genetics|October 11, 2020
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trialJan Boeckhaus, Julia Hoefele, Korbinian M Riedhammer, et al.
Journal of Clinical Medicine|July 24, 2021
Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort StudyOliver Gross, Onnen Moerer, Thomas Rauen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trialsEmmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
European Heart Journal|December 19, 2025
Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trialJaved Butler, Muhammad Shahzeb Khan, Tim Friede, et al.
Journal of Molecular and Cellular Cardiology|September 9, 2022
Direct proteomic and high-resolution microscopy biopsy analysis identifies distinct ventricular fates in severe aortic stenosisSören Brandenburg, Lena Drews, Hanne-Lea Schönberger, et al.
Orphanet Journal of Rare Diseases|October 26, 2018
Recent advances in methodology for clinical trials in small populations: the InSPiRe projectTim Friede, Martin Posch, Sarah Zohar, et al.
Kidney International|April 18, 2020
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndromeOliver Gross, Burkhard Tönshoff, Lutz T Weber, et al.
BMC Cancer|February 6, 2025
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trialMichael Ghadimi, Uwe Pelzer, Marc G Besselink, et al.
Data in Brief|December 12, 2018
Data on differential multivariable risk prediction of appropriate shock vs. competing mortalityLeonard Bergau, Rik Willems, David J Sprenkeler, et al.
American Heart Journal|April 30, 2017
Toward evidence-based diagnosis of myocarditis in children and adolescents: Rationale, design, and first baseline data of MYKKE, a multicenter registry and study platformDaniel R Messroghli, Thomas Pickardt, Marcus Fischer, et al.
Pageof 40